These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 36653533)
21. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial. Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576 [TBL] [Abstract][Full Text] [Related]
22. Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort. Thorius IH; Husemoen LLN; Nordsborg RB; Alibegovic AC; Gall MA; Petersen J; Damm P; Mathiesen ER Diabetes Care; 2024 Mar; 47(3):384-392. PubMed ID: 38128075 [TBL] [Abstract][Full Text] [Related]
23. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin. Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840 [TBL] [Abstract][Full Text] [Related]
24. Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study. Ogassavara J; Dualib PM; Mattar R; Dib SA; de Almeida-Pititto B Arch Endocrinol Metab; 2023 Jun; 67(6):e220483. PubMed ID: 37364140 [TBL] [Abstract][Full Text] [Related]
25. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial. Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907 [TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524 [TBL] [Abstract][Full Text] [Related]
27. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey. Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715 [No Abstract] [Full Text] [Related]
28. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691 [TBL] [Abstract][Full Text] [Related]
29. A comparative study using insulin pump therapy and continuous glucose monitoring in newly diagnosed very young children with type 1 diabetes: it is possible to bend the curve of HbA1c. Castorani V; Favalli V; Rigamonti A; Frontino G; Di Tonno R; Morotti E; Sandullo F; Scialabba F; Arrigoni F; Dionisi B; Foglino R; Morosini C; Olivieri G; Barera G; Meschi F; Bonfanti R Acta Diabetol; 2023 Dec; 60(12):1719-1726. PubMed ID: 37526745 [TBL] [Abstract][Full Text] [Related]
30. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial. Moreno-Fernandez J; Gómez FJ; Gálvez Moreno MÁ; Castaño JP J Diabetes Res; 2016; 2016():4171789. PubMed ID: 28004007 [No Abstract] [Full Text] [Related]
31. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland. Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM; Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483 [TBL] [Abstract][Full Text] [Related]
32. Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes. Sibiak R; Gutaj P; Mrzewka-Rogacz B; Mantaj U; Wender-Ozegowska E Diabetes Technol Ther; 2022 Jan; 24(1):42-53. PubMed ID: 34524000 [No Abstract] [Full Text] [Related]
33. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System. Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682 [No Abstract] [Full Text] [Related]
34. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis. Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367 [TBL] [Abstract][Full Text] [Related]
35. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes. Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494 [No Abstract] [Full Text] [Related]
36. Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes. Quirós C; Herrera Arranz MT; Amigó J; Wägner AM; Beato-Vibora PI; Azriel-Mira S; Climent E; Soldevila B; Barquiel B; Colomo N; Durán-Martínez M; Corcoy R; Codina M; Díaz-Soto G; Márquez Pardo R; Martínez-Brocca MA; Rebollo Román Á; López-Gallardo G; Cuesta M; García Fernández J; Goya M; Vega Guedes B; Mendoza Mathison LC; Perea V Diabetes Technol Ther; 2024 Aug; 26(8):596-606. PubMed ID: 38417014 [No Abstract] [Full Text] [Related]
37. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes. Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725 [TBL] [Abstract][Full Text] [Related]
38. Patient Controlled, Off-label Use of Continuous Glucose Monitoring: Real-World Medical Costs and Effects of Patient Controlled Sensor Augmented Pump Therapy in Adult Patients Type 1 Diabetes. Hidefjäll P; Berg L J Diabetes Sci Technol; 2021 May; 15(3):575-581. PubMed ID: 32517514 [TBL] [Abstract][Full Text] [Related]
39. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584 [TBL] [Abstract][Full Text] [Related]
40. Mediating Effects of Technology-Based Therapy on the Relationship Between Socioeconomic Status and Glycemic Management in Pediatric Type 1 Diabetes. Stanley JR; Clarke ABM; Shulman R; Mahmud FH Diabetes Technol Ther; 2023 Mar; 25(3):186-193. PubMed ID: 36409503 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]